KR890014103A - 항 바이러스성과 면역 촉진의 약학적 조성과 제조의 제조방법 - Google Patents

항 바이러스성과 면역 촉진의 약학적 조성과 제조의 제조방법 Download PDF

Info

Publication number
KR890014103A
KR890014103A KR1019890002920A KR890002920A KR890014103A KR 890014103 A KR890014103 A KR 890014103A KR 1019890002920 A KR1019890002920 A KR 1019890002920A KR 890002920 A KR890002920 A KR 890002920A KR 890014103 A KR890014103 A KR 890014103A
Authority
KR
South Korea
Prior art keywords
acid
active ingredients
lysine
composition
amino
Prior art date
Application number
KR1019890002920A
Other languages
English (en)
Korean (ko)
Inventor
리테라티 나기 페테르
보로스 마리아
스질베레키 예노
라크츠 이스트반
수스 곤기베르
콜터 미크로스
핀터 알란
네베스 가보트
Original Assignee
원본미기재
비오렉스 케이 에프 티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 비오렉스 케이 에프 티 filed Critical 원본미기재
Publication of KR890014103A publication Critical patent/KR890014103A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019890002920A 1988-03-09 1989-03-09 항 바이러스성과 면역 촉진의 약학적 조성과 제조의 제조방법 KR890014103A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1132/88 1988-03-09
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition

Publications (1)

Publication Number Publication Date
KR890014103A true KR890014103A (ko) 1989-10-21

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890002920A KR890014103A (ko) 1988-03-09 1989-03-09 항 바이러스성과 면역 촉진의 약학적 조성과 제조의 제조방법

Country Status (14)

Country Link
JP (1) JPH01316316A (fi)
KR (1) KR890014103A (fi)
BE (1) BE1002890A3 (fi)
CA (1) CA1334576C (fi)
CH (1) CH678918A5 (fi)
DE (1) DE3907649C2 (fi)
FI (1) FI94591C (fi)
FR (1) FR2628324B1 (fi)
GB (1) GB2216418B (fi)
HU (1) HU209973B (fi)
IT (1) IT1229562B (fi)
LU (1) LU87471A1 (fi)
NL (1) NL8900574A (fi)
SE (1) SE8900828L (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
WO1994022438A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
AU5002196A (en) * 1995-03-28 1996-10-16 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2219639A1 (en) * 2007-12-17 2010-08-25 University of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
CA3025425A1 (en) * 2016-05-25 2017-11-30 Evonik Technochemie Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
EP3648748A1 (en) 2017-07-06 2020-05-13 Evonik Operations GmbH Enteric coated solid dosage form comprising omega-3 fatty acid amino acid salts
US11622952B2 (en) 2017-08-15 2023-04-11 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
CA3146612A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Down streaming process for the production of polyunsaturated fatty acid salts
EP4009961A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (fi) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
DE3785667T2 (de) * 1986-09-17 1994-07-21 Clintec Nutrition Co Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen.
AU1489688A (en) * 1987-02-20 1988-09-14 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
GB8905385D0 (en) 1989-04-19
FR2628324B1 (fr) 1994-05-27
DE3907649C2 (de) 1996-07-11
GB2216418A (en) 1989-10-11
GB2216418B (en) 1991-12-11
HUT60432A (en) 1992-09-28
BE1002890A3 (fr) 1991-07-16
NL8900574A (nl) 1989-10-02
SE8900828D0 (sv) 1989-03-09
IT8919704A0 (it) 1989-03-09
DE3907649A1 (de) 1989-09-28
FI94591B (fi) 1995-06-30
IT1229562B (it) 1991-09-04
FI94591C (fi) 1995-10-10
CA1334576C (en) 1995-02-28
LU87471A1 (fr) 1990-10-02
CH678918A5 (fi) 1991-11-29
FI891145A0 (fi) 1989-03-09
FR2628324A1 (fr) 1989-09-15
FI891145A (fi) 1989-09-10
JPH01316316A (ja) 1989-12-21
SE8900828L (sv) 1989-09-10
HU209973B (en) 1995-01-30

Similar Documents

Publication Publication Date Title
KR890014103A (ko) 항 바이러스성과 면역 촉진의 약학적 조성과 제조의 제조방법
EP1961312A3 (en) Microbial oil mixture and uses thereof
MX171547B (es) Composicion aditiva para fluidos de aceite/agua
DK0950410T3 (da) Konjugeret linolsyresammensætninger
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
ATE119033T1 (de) Eine dispersion von lipidvesikeln enthaltende kosmetika oder arznei- bzw. nahrungsmittel.
ATE90663T1 (de) Aluminium-magnesium-hydroxi-fettsaeure-verbindun enthaltende gelzusammensetzumg.
KR880014090A (ko) 연성세제 조성물
MX173159B (es) Composicion liquida de detergente para lavar vajillas, para trabajo ligero, que contienen agentes tenisioactivos de polisacarido de alquilo y ester alquilico de acido graso alfa-sulfonado
BR9812835A (pt) Composição de gel para barbear não-aerossol
SE8901041L (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
US4948521A (en) Metalworking composition
KR880007069A (ko) 트리글리세라이드 조성물
KR870008011A (ko) 알루미늄 및 알루미늄 합금용 냉간압연 오일 조성물
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
KR890014451A (ko) 신규 염류 형태의 화합물, 이들을 함유하는 약학적 조성물 및 이 화합물을 제조하는 방법
ES2064200B1 (es) Compuesto para la eliminacion de tintas.
KR920019345A (ko) 아이코사펜타노산 및 α-리놀렌산을 함유하는 여드름 치료제 조성물
JPS642551A (en) Dietary composition and its production
KR890000080A (ko) 점도가 증가된 국소용 오일조성물 및 이의 제조방법
KR960041239A (ko) 재생가능한 원료로부터 제조된 수성의 외부적으로 유화된 알키드 수지 에멀젼
SE8800988D0 (sv) Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
KR900005955A (ko) 페이스트상 치아 연마 조성물
BR9801348A (pt) Composição de revestimento e método para intensificar as propriedades de deslizamento em uma composição de revestimento
EP0162924A4 (en) 5-FLUORURACILA COMBS AND MEDICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid